Univest
Univest
  • Markets

Kingfa Science Q1 FY27 Results: Revenue Rs 689 Cr, PAT Rs 80 Cr

  • August 17, 2026
  • Posted by: Neeraj Pandey
  • Category: Market
No Comments
Kingfa Science Q1 FY27 Results: Revenue Rs 689 Cr, PAT Rs 80 Cr

Kingfa Science Q1 FY27: Revenue Rs 689 Cr (+49% YoY). PAT Rs 80 Cr (+100% YoY). Gross Profit Rs 103 Cr. Standalone. CMP Rs 6015.00 on Aug 14, 2026.

Quick Answer

Kingfa Science Q1 FY27 results showed standalone revenue of Rs 689 crore (+49% YoY) with pat of Rs 80 crore (+100% YoY) and gross profit of Rs 103 crore. Results announced on August 14, 2026.

Kingfa Science Q1 FY27 results showed standalone revenue at Rs 689 crore, compared to Rs 462 crore in Q1 FY26 — a +49% change. The company operates across its core business segments and reported these Q1 FY27 results on August 14, 2026.

The Kingfa Science Q1 FY27 results showed gross profit of Rs 103 crore (+98% YoY) versus Rs 52 crore in Q1 FY26. The pat of Rs 80 crore (+100% YoY) versus Rs 40 crore reflects the overall operating and financial outcome for the quarter.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Kingfa Science Q1 FY27 Financial Highlights
  • Kingfa Science Q1 FY27 Performance Analysis
  • Key Business Factors in Q1 FY27
    • Revenue Performance
    • Margin and Cost Dynamics
    • PAT Outcome
  • Dividend Details
  • FY27 Outlook
  • Kingfa Science Stock Performance
  • Key Risks
    • Revenue Growth Sustainability
    • Margin Management
    • Macro and Sector Risks
  • Conclusion
  • Frequently Asked Questions on Kingfa Science Q1 FY27 Results
    • When were Kingfa Science Q1 FY27 results announced?
    • What was Kingfa Science’s revenue in Q1 FY27?
    • What was Kingfa Science’s pat in Q1 FY27?
    • What drove Kingfa Science’s Q1 FY27 performance?
    • Did Kingfa Science declare a dividend for Q1 FY27?
    • What is the outlook for Kingfa Science after Q1 FY27 results?
    • Is Kingfa Science a good investment after Q1 FY27 results?

Kingfa Science Q1 FY27 Financial Highlights

Metric Q1 FY27 (Rs Crore) Q1 FY26 (Rs Crore) YoY Change
Revenue 689 462 +49%
Gross Profit 103 52 +98%
PAT / PAT 80 40 +100%

Kingfa Science Q1 FY27 Performance Analysis

Use the Univest Screener to track Kingfa Science live financials and Q1 FY27 results

Kingfa Science Q1 FY27 results showed revenue of Rs 689 crore (+49% YoY), reflecting the prevailing market conditions and the company’s operational execution across its primary business segments.

Gross Profit at Rs 103 crore (+98% YoY) in Kingfa Science Q1 FY27 results captures the direct cost economics — input costs, manufacturing or service delivery expenses — relative to the revenue generated in Q1 FY27.

The pat of Rs 80 crore (+100% YoY) in Kingfa Science Q1 FY27 results represents the bottom-line outcome after accounting for all operating expenses, other income, and below-gross-profit costs.

Investors should evaluate Kingfa Science Q1 FY27 results in the context of industry growth rates, the company’s competitive position, cost structure, and management’s FY27 guidance to form a comprehensive investment view.

Key Business Factors in Q1 FY27

Revenue Performance

Kingfa Science Q1 FY27 results show revenue of Rs 689 crore (+49% YoY). Revenue trend reflects sector demand dynamics, competitive intensity, and the company’s market positioning in Q1 FY27.

Margin and Cost Dynamics

Gross Profit of Rs 103 crore (+98% YoY) in Kingfa Science Q1 FY27 results reflects input cost trends, pricing power, and operational efficiency in the quarter.

PAT Outcome

The pat of Rs 80 crore (+100% YoY) captures the overall financial performance including both operational results and non-operating income or charges in Q1 FY27 results.

Dividend Details

Kingfa Science has not declared a dividend for Q1 FY27. Annual dividend consideration will depend on full-year FY27 performance.

FY27 Outlook

The FY27 outlook for Kingfa Science will be shaped by the revenue and margin trajectory visible from Q1 FY27 results. Key factors include sector demand trends, input cost management, competitive dynamics, and management’s execution capability.

Investors should monitor Q2 FY27 results for confirmation of the trends observed in Kingfa Science Q1 FY27 results, particularly regarding revenue growth sustainability and margin progression.

Kingfa Science Stock Performance

Download the Univest iOS App or Univest Android App to track Kingfa Science share price live and stay updated on quarterly results.

Kingfa Science shares traded at Rs 6015.00 on August 14, 2026. The stock’s movement reflects the market’s immediate assessment of Q1 FY27 results in the context of prevailing sector valuations and growth expectations.

Key Risks

Revenue Growth Sustainability

Maintaining or improving the revenue trajectory from Kingfa Science Q1 FY27 results depends on sector demand, competitive dynamics, and successful business development initiatives.

Margin Management

Gross and net margin sustainability in Kingfa Science Q1 FY27 results and subsequent quarters is subject to input cost trends, pricing competition, and operational efficiency.

Macro and Sector Risks

Broader macroeconomic conditions, interest rate trends, and sector-specific regulatory changes could impact Kingfa Science’s earnings trajectory from Q1 FY27 results.

Conclusion

Kingfa Science Q1 FY27 results show revenue of Rs 689 crore (+49% YoY) and pat of Rs 80 crore (+100% YoY) — reflecting the company’s operating performance for April to June 2026.

Investors should conduct detailed sector and company-specific analysis, assess management strategy and guidance, before making investment decisions. Consult a SEBI-registered financial advisor.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Kingfa Science Q1 FY27 Results

When were Kingfa Science Q1 FY27 results announced?

Ans. Kingfa Science Q1 FY27 results were announced on August 14, 2026, covering the April to June 2026 quarter on a standalone basis.

What was Kingfa Science’s revenue in Q1 FY27?

Ans. Kingfa Science reported standalone revenue of Rs 689 crore in Q1 FY27, +49% from Rs 462 crore in Q1 FY26.

What was Kingfa Science’s pat in Q1 FY27?

Ans. Kingfa Science’s pat was Rs 80 crore in Q1 FY27, +100% from Rs 40 crore in Q1 FY26.

What drove Kingfa Science’s Q1 FY27 performance?

Ans. Kingfa Science Q1 FY27 results reflect the company’s sector positioning, operational execution, cost management, and prevailing market conditions in April-June 2026.

Did Kingfa Science declare a dividend for Q1 FY27?

Ans. No dividend has been declared for Q1 FY27. Annual dividend prospects will depend on full-year FY27 earnings performance.

What is the outlook for Kingfa Science after Q1 FY27 results?

Ans. The FY27 outlook depends on revenue and margin sustainability from Q1 FY27 results, sector demand trends, and management guidance for the rest of FY27.

Is Kingfa Science a good investment after Q1 FY27 results?

Ans. Kingfa Science Q1 FY27 results provide the latest financial update. Investors should assess sector positioning, valuation, and growth prospects before investing. Consult a SEBI-registered advisor.



News
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply